Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE

v3.24.2.u1
EARNINGS (LOSS) PER SHARE
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
EARNINGS (LOSS) PER SHARE EARNINGS (LOSS) PER SHARE
Basic earnings per share represents income available to ordinary shareholders divided by the weighted average number of Ordinary Shares outstanding during the reported period. Diluted earnings per share is based upon the weighted-average number of Ordinary Shares outstanding during the period plus additional weighted-average potentially dilutive Ordinary Share equivalents during the period when the effect is dilutive.
Basic and diluted weighted average shares outstanding and (loss) earnings per share were as follows (in thousands, except share and per share data):
Three Months Ended June 30, Six Months Ended June 30,
2024 2023 2024 2023
Net income (loss) $ 21,650  $ 52,014  $ (60,908) $ 61,445 
Weighted-average shares outstanding:
Weighted average shares used in computing earnings (loss) per share, basic 145,236,526  156,525,006  145,279,938  157,109,418 
Founders advisory fees 9,428,244  11,785,305  —  11,785,305 
Weighted average shares used in computing earnings (loss) per share, diluted 154,664,770  168,310,311  145,279,938  168,894,723 
Basic earnings (loss) per share $ 0.15  $ 0.33  $ (0.42) $ 0.39 
Diluted earnings (loss) per share $ 0.14  $ 0.31  $ (0.42) $ 0.36 
As of June 30, 2024, 14.6 million PBNQSO and 23.1 million Ordinary Shares issuable under the Founder Advisory Agreement towards Variable Annual Advisory Amount were excluded from the diluted earnings per share calculation as the contingencies related to such instruments had not been met. In addition, 8.5 million Ordinary Shares equivalent
warrants and 9.4 million Ordinary Shares issuable under the Founder Advisory Agreement towards Fixed Annual Advisory Amount were excluded, as applicable, from the diluted earnings per share calculation as their effect would have been anti-dilutive. As of June 30, 2023, 11.2 million PBNQSOs and 17.6 million Ordinary Shares issuable under the Founder Advisory Agreement were excluded from the diluted earnings per share calculation as the contingencies related to such instruments had not been met. In addition, 8.5 million Ordinary Shares equivalent warrants were excluded from the diluted earnings per share calculation as their effect would have been anti-dilutive.